Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. This drug is designed to treat adults suffering from Nasopharyngeal carcinoma (NPC), a rare and aggressive form of head and neck cancer that originates in the nasopharynx, the upper part of the throat.